EUVIMEDEUVIMED entdecken
Crossref

Adverse myocardial and vascular side effects of immune checkpoint inhibitors: a prospective multimodal cardiovascular assessment

Mariana Mirabel, Assié Eslami, Constance Thibault, Stéphane Oudard, Elie Mousseaux, Karim Wahbi, Elizabeth Fabre, Benjamin Terrier, Eloi Marijon, Aurélie Villefaillot, Antoine Fayol, Marie-Agnès Dragon-Durey und 4 weitere

Clinical Research in Cardiology · 2024

DOI: 10.1007/s00392-024-02462-x ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Research in Cardiology, 2024. Verfasst von Mariana Mirabel und 15 weiteren Autor:innen. Beteiligte Einrichtung: Cardiology, Institut Mutualiste Montsouris, 42 bd Jourdan, 75014, Paris, France. mariana.mirabel@imm.fr. Hauptthemen laut MEDLINE: Immune Checkpoint Inhibitors, Neoplasms, Cardiovascular Diseases. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: Fondation pour la Recherche Médicale, Fédération Française de Cardiologie.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immune Checkpoint InhibitorsNeoplasmsCardiovascular DiseasesIncidenceProspective StudiesHumansCardiotoxicityHeart FailureArrhythmias, CardiacEchocardiographyRisk FactorsMultimodal ImagingMagnetic Resonance Imaging, CineHeartMaleFemaleMiddle AgedAged

Stichwörter der Autor:innen

ArrhythmiasCancerCardiac magentic resonanceHeart failureImmunotherapies

Substanzen

Immune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Cardiology, Institut Mutualiste Montsouris, 42 bd Jourdan, 75014, Paris, France. mariana.mirabel@imm.fr.
  • Université Paris Cité, INSERM, PARCC, F-75015, Paris, France. mariana.mirabel@imm.fr.
  • Cardiology, DMU CARTE, AP-HP, Hôpital Européen Georges-Pompidou, F-75015, Paris, France.
  • Oncology, AP-HP, Hôpital Européen Georges-Pompidou, F-75015, Paris, France.
  • Université Paris Cité, INSERM, PARCC, F-75015, Paris, France.
  • Radiology, AP-HP, Hôpital Européen Georges-Pompidou, F-75015, Paris, France.

Förderung

  • Fondation pour la Recherche Médicale
  • Fédération Française de Cardiologie

Zitieren

APA

Mirabel, M., Eslami, A., Thibault, C., Oudard, S., Mousseaux, E., Wahbi, K., Fabre, E., Terrier, B., Marijon, E., Villefaillot, A., Fayol, A., Dragon-Durey, M. A., Le Louet, A. L., Bruno, R. M., Soulat, G., & Hulot, J. S. (2024). Adverse myocardial and vascular side effects of immune checkpoint inhibitors: a prospective multimodal cardiovascular assessment. Clinical Research in Cardiology. https://doi.org/10.1007/s00392-024-02462-x

Vancouver

Mirabel M, Eslami A, Thibault C, Oudard S, Mousseaux E, Wahbi K, et al. Adverse myocardial and vascular side effects of immune checkpoint inhibitors: a prospective multimodal cardiovascular assessment. Clinical Research in Cardiology. 2024. doi:10.1007/s00392-024-02462-x

BibTeX
@article{Mirabel2024,
  author = {Mirabel, Mariana and Eslami, Assié and Thibault, Constance and Oudard, Stéphane and Mousseaux, Elie and Wahbi, Karim and Fabre, Elizabeth and Terrier, Benjamin and Marijon, Eloi and Villefaillot, Aurélie and Fayol, Antoine and Dragon-Durey, Marie-Agnès and Le Louet, Agnès Lillo and Bruno, Rosa Maria and Soulat, Gilles and Hulot, Jean Sébastien},
  title = {Adverse myocardial and vascular side effects of immune checkpoint inhibitors: a prospective multimodal cardiovascular assessment},
  journal = {Clinical Research in Cardiology},
  year = {2024},
  doi = {10.1007/s00392-024-02462-x}
}
Kostenlos starten →